Omnicell, Inc. - Common Stock (NQ:OMCL)

37.19 +0.22 (+0.58%)

Delayed Quote Updated: 10:32 AM EDT, Oct 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Omnicell, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Omnicell to Present at the Piper Sandler 37th Annual Healthcare Conference

November 20, 2025

From Omnicell, Inc.

Via Business Wire

Omnicell Achieves URAC Certification, Strengthening Compliance and Scalability for Health System-Owned Specialty Pharmacies

November 13, 2025

From Omnicell, Inc.

Via Business Wire

3 Russell 2000 Stocks with Warning Signs

November 06, 2025

Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resources than their bigger counterparts, these...

Via StockStory

Earnings Scheduled For October 30, 2025 ↗

October 30, 2025

Via Benzinga

Analyst Expectations For Omnicell's Future ↗

August 11, 2025

Via Benzinga

Earnings Scheduled For July 31, 2025 ↗

July 31, 2025

Via Benzinga

Why Omnicell Stock Crushed the Market Today ↗

October 30, 2025

The company continues to benefit from demand for its next-generation healthcare tech offerings.

Via The Motley Fool

Why Omnicell (OMCL) Stock Is Trading Up Today

October 30, 2025

Shares of healthcare tech company Omnicell (NASDAQ:OMCL) jumped 10.9% in the morning session after the company reported strong third-quarter 2025 financial results that beat expectations and raised its...

Via StockStory

Omnicell Inc (NASDAQ:OMCL) Surpasses Q3 2025 Estimates, Stock Rises on Strong Guidance ↗

October 30, 2025

Omnicell (OMCL) Q3 2025 earnings beat estimates, with revenue of $310.6M and non-GAAP EPS of $0.51. The stock rose 8% pre-market on the strong results and raised guidance.

Via Chartmill

Topics Earnings

Omnicell (NASDAQ:OMCL) Reports Bullish Q3, Stock Soars

October 30, 2025

Healthcare tech company Omnicell (NASDAQ:OMCL) reported Q3 CY2025 results beating Wall Street’s revenue expectations, with sales up 10% year on year to $310.6 million. On top of that, next quarter’s...

Via StockStory

Omnicell Announces Third Quarter 2025 Financial Results

October 30, 2025

From Omnicell, Inc.

Via Business Wire

Omnicell (OMCL) To Report Earnings Tomorrow: Here Is What To Expect

October 28, 2025

Healthcare tech company Omnicell (NASDAQ:OMCL) will be announcing earnings results this Thursday morning. Here’s what you need to know.

Via StockStory

Topics Artificial Intelligence

3 of Wall Street’s Favorite Stocks That Concern Us

October 27, 2025

Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional...

Via StockStory

Healthcare Technology Stocks Q2 Highlights: Tandem Diabetes (NASDAQ:TNDM)

October 26, 2025

Looking back on healthcare technology stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Tandem Diabetes (NASDAQ:TNDM) and its peers.

Via StockStory

Q2 Rundown: Privia Health (NASDAQ:PRVA) Vs Other Healthcare Technology for Providers Stocks

October 20, 2025

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how healthcare technology for providers stocks fared in Q2,...

Via StockStory

Q2 Earnings Highs And Lows: Premier (NASDAQ:PINC) Vs The Rest Of The Healthcare Technology for Providers Stocks

October 14, 2025

As the Q2 earnings season wraps, let’s dig into this quarter’s best and worst performers in the healthcare technology for providers industry, including Premier (NASDAQ:PINC) and its peers.

Via StockStory

Topics Economy

Myriad Genetics, Omnicell, Globus Medical, Repligen, and Teleflex Stocks Trade Down, What You Need To Know

October 10, 2025

A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump.

Via StockStory

Topics Economy Government World Trade

Omnicell to Release Third Quarter 2025 Financial Results on October 30, 2025

October 06, 2025

From Omnicell, Inc.

Via Business Wire

1 Stock Under $50 with Promising Prospects and 2 Facing Challenges

October 02, 2025

Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However, investors should remain vigilant as some...

Via StockStory

3 Cash-Producing Stocks We Keep Off Our Radar

September 18, 2025

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.

Via StockStory

3 Cash-Heavy Stocks We Approach with Caution

September 15, 2025

A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow.

Via StockStory

3 Low-Volatility Stocks We Steer Clear Of

September 05, 2025

Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies.

Via StockStory

Topics Retirement

Q2 Earnings Highlights: Omnicell (NASDAQ:OMCL) Vs The Rest Of The Healthcare Technology for Providers Stocks

August 27, 2025

Looking back on healthcare technology for providers stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Omnicell (NASDAQ:OMCL) and its peers.

Via StockStory

Omnicell Appoints Baird Radford as Executive Vice President and Chief Financial Officer

August 25, 2025

From Omnicell, Inc.

Via Business Wire

2 Profitable Stocks Worth Investigating and 1 Facing Challenges

August 25, 2025

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.

Via StockStory

OMCL Q2 Deep Dive: Product Innovation and Recurring Revenue Drive Upbeat Guidance

August 13, 2025

Healthcare tech company Omnicell (NASDAQ:OMCL) reported Q2 CY2025 results beating Wall Street’s revenue expectations, with sales up 5% year on year to $290.6 million. On top of that, next quarter’s...

Via StockStory

Topics World Trade

Bruker, Viatris, Sotera Health Company, Align Technology, and Omnicell Stocks Trade Up, What You Need To Know

August 12, 2025

A number of stocks jumped in the afternoon session after positive inflation data fueled hopes for an interest rate cut by the Federal Reserve. The latest Consumer Price Index (CPI) report showed...

Via StockStory

Topics Bonds Economy Stocks

1 Small-Cap Stock for Long-Term Investors and 2 We Avoid

August 08, 2025

Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a...

Via StockStory

Omnicell (NASDAQ:OMCL) Reports Upbeat Q2, Full-Year Outlook Slightly Exceeds Expectations

July 31, 2025

Healthcare tech company Omnicell (NASDAQ:OMCL) announced better-than-expected revenue in Q2 CY2025, with sales up 5% year on year to $290.6 million. On top of that, next quarter’s revenue guidance...

Via StockStory

Omnicell Announces Second Quarter 2025 Results

July 31, 2025

From Omnicell, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.